Combination regimen of intravesical docetaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive bladder cancer: clinical outcomes and genomic correlations

Joffe, B. I., Christin, J. R., Le Coz, C., Gorroochurn, P., Pak, J. S., Laplaca, C., Reyes, H. V., DeCastro, G. J., Anderson, C. B., Abate-Shen, C., Shen, M. M., McKiernan, J. M., & Lenis, A. T. (2025). Combination regimen of intravesical docetaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive bladder cancer: clinical outcomes and genomic correlations. Urologic Oncology: Seminars and Original Investigations. https://doi.org/10.1016/j.urolonc.2025.05.012
Authors:
Benjamin I Joffe
John R Christin
Clémentine Le Coz
Prakash Gorroochurn
Jamie S Pak
Caroline Laplaca
Helena Vila Reyes
G Joel DeCastro
Christopher B Anderson
Cory Abate-Shen
Michael M Shen
James M McKiernan
Andrew T Lenis
Affiliated Authors:
Benjamin I Joffe
John R Christin
Clémentine Le Coz
Prakash Gorroochurn
Jamie S Pak
Caroline Laplaca
Helena Vila Reyes
G Joel DeCastro
Christopher B Anderson
Cory Abate-Shen
Michael M Shen
James M McKiernan
Andrew T Lenis
Author Keywords:
bcg
bladder cancer
intravesical instillation
Publication Type:
Article
Unique ID:
10.1016/j.urolonc.2025.05.012
PMID:
Publication Date:
Data Source:
PubMed

Record Created: